Converting Insulin Infusion to Subcutaneous Insulin
Introduction to Insulin Conversion
- The American Diabetes Association recommends administering subcutaneous basal insulin 2 hours before discontinuing the IV insulin infusion, using 50% of the total 24-hour IV insulin dose as long-acting basal insulin and dividing the remaining 50% equally as rapid-acting insulin before each meal 1, 2
Calculate the Total Daily Dose
- Determine the average hourly IV insulin infusion rate during the prior 6-8 hours when glucose levels have been stable, then multiply by 24 to calculate the total daily insulin requirement 1, 2
- For example, if a patient received an average of 1.5 units/hour during stable glycemic control, the estimated total daily dose would be 36 units (1.5 × 24 = 36 units) 3
Divide Into Basal and Prandial Components
- Give 50% of the calculated total daily dose as once-daily long-acting basal insulin administered subcutaneously 1, 2, 5
- Divide the remaining 50% equally into three doses of rapid-acting insulin to be given before each meal 1, 2, 5
Critical Timing to Prevent Rebound Hyperglycemia
- Administer the first dose of subcutaneous basal insulin exactly 2 hours before stopping the IV insulin infusion to allow adequate absorption and prevent dangerous rebound hyperglycemia 1, 2, 5
Add Correctional Insulin
- Prescribe supplemental rapid-acting insulin using a correction scale to address hyperglycemia between scheduled doses 6, 3
- A typical correction factor is 1 unit of rapid-acting insulin per 50 mg/dL above target glucose 7
Prerequisites Before Transition
- Ensure glucose levels have been stable for at least 4-6 hours consecutively on the IV insulin infusion before initiating transition 6, 3, 7
- Confirm hemodynamic stability and that the patient has a stable nutrition plan or is able to eat 6, 3
Special Populations Requiring Dose Adjustment
- Reduce the starting dose to 0.15-0.2 units/kg total daily dose in elderly patients, those with renal insufficiency, or patients with poor oral intake to minimize hypoglycemia risk 1, 3
- For patients with known diabetes previously on insulin at home, reduce their home total daily dose by 20% rather than calculating from IV insulin rates 6
Intensive Monitoring Requirements
- Check capillary blood glucose before each meal and at bedtime during the first 24-48 hours after transition 6, 3
- Monitor serum potassium closely as subcutaneous insulin continues to drive potassium intracellularly, potentially causing life-threatening hypokalemia and cardiac arrhythmias 7
Common Pitfalls to Avoid
- Never stop the IV insulin infusion before administering subcutaneous basal insulin—this single error causes rebound hyperglycemia, recurrent DKA/HHS, and increased hospital complications 1, 5, 7
- Never use sliding scale (correction-only) insulin alone without scheduled basal and prandial insulin in patients with known diabetes, as this approach is associated with worse outcomes and higher complication rates 6, 3, 7